Maksym MinasyanView profile
Researcher
Maksym Minasyan is a researcher affiliated with the Yale School of Medicine, holding a BS in Biology/Genetics and an MD from Lviv National University and Lviv National Medical University (2014). His research focuses on immune responses, respiratory diseases, and viral infections, particularly in the context of SARS-CoV-2 (COVID-19), sarcoidosis, and interstitial lung diseases. He collaborates extensively with colleagues like Wonnie Ryu, Naftali Kaminski, and Albert Ko on projects investigating cytokine dynamics, mitochondrial DNA roles in disease progression, and biomarker discovery for clinical outcomes. His work spans immunology, virology, and molecular biology, with notable contributions to understanding how cytokines like IL-15 influence pulmonary conditions and how viral infections affect systemic immunity. He has pioneered saliva-based diagnostic methods for SARS-CoV-2 and explored the gut microbiome's role in infection severity. Despite no explicit awards listed, his research portfolio indicates significant contributions to translational medicine and infectious disease pathogenesis. Minasyan’s publications reflect a multidisciplinary approach, integrating single-cell analyses, biomarker studies, and clinical data. He has investigated the role of immune cells in idiopathic pulmonary fibrosis and the impact of viral infections on maternal-fetal interfaces. His recent studies highlight the importance of mitochondrial DNA in extrapulmonary sarcoidosis and SSc-ILD progression.







